Refine by
Mitral Valve Articles & Analysis
26 news found
MitraClip is a procedure that approximates the mitral valve leaflets thereby addressing an incompetent valve that is regurgitating, also known as “leaking.” Significant mitral regurgitation prevalence rates are estimated to be up to 10% to 25% in patients in their seventies. During the procedure, operators implant one ...
“I am excited to join the talented team at InnovHeart at this pivotal time of focus and commitment to significantly advancing Transcatheter Mitral Valve Replacement (TMVR) procedures enabled by our transformational Saturn platform,” said Mr. ...
” The reSept ASD Occluder aims to address the limitations of current occluders which have metallic frames that can place patients at risk of complications associated with long-term presence of metal in the heart and may limit future transseptal interventions, such as mitral valve interventions. Initial clinical experience demonstrates positive safety and ...
Milan, January 27, 2022 – InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announces the closing of its Series C financing with granting an exclusive licensing agreement to Grand Pharmaceutical Group Limited, (Grand Pharma) for its ...
FDA approval for the Trilogy Heart Valve System.” “With the addition of the TrilogyTM, Peijia will have a more comprehensive product portfolio to better serve patients with aortic valve diseases in China,” said Dr. ...
BIOMODEX®, the leader in biorealistic haptic simulators for physician training and rehearsals, and the Montreal Heart Institute (MHI), a world-renowned, ultra-specialized cardiology center, announced they are partnering to develop a new cardiovascular training solution to help cardiologists rehearse and train for complex valve-in-valve procedures. The teams ...
ByBIOMODEX
In a retrospective study entitled “Intraoperative Hemoadsorption Reduces Sepsis-related Death in All-comers Undergoing Surgery for Infective Left-sided Endocarditis,” investigators from Nuremberg, Germany report results from 195 consecutive patients with left-sided endocarditis (i.e. aortic and/or mitral valve involvement) who underwent ...
In addition, the Carillon Mitral Contour System can now be considered under the new Class IIb 2021 Guidelines for the Management of Valvular Heart Disease recommendations on indications for mitral valve intervention in chronic severe secondary mitral regurgitation. ...
Dr Meduri is a recognized leader in the field of valvular heart disease, serving as the national principle investigator of several valve trials and on numerous steering committees. He has performed first-in-US and first-in-world procedures, led enrollment in many trials and actively participated in 11 transcatheter early feasibility studies. ...
The combination of quality data, along with the trial being the only blinded, randomized, sham-controlled study performed in the mitral valve space, will make The EMPOWER Trial a landmark clinical study in the area of heart failure. ...
Here is our ultimate list, compiled from analyst reports, of private medtech companies to watch. 4C Medical 4C Medical is developing the AltaValve, a transcatheter mitral valve replacement (TMVR) platform designed to address mitral regurgitation (MR). It is the first transcatheter mitral regurgitation (MR) therapy that directly ...
The series titled “A Case Series of the BioTrace Medical Tempo Active Fixation Lead in Cardiac Surgery—A Novel Technique for Post-Surgical Pacemaking,” describes a collection of re-operative robotic mitral valve surgeries performed at Thomas Jefferson University Hospital in Philadelphia, Pa. in which the Tempo Lead was successfully utilized for ...
This data shows we are breaking new ground and are excited to advance our unique FMR treatment.” About the Carillon Mitral Contour System® The Carillon System offers a simple right heart approach to transcatheter mitral valve repair designed to reshape the anatomy and function of the mitral apparatus from the coronary ...
He holds a B.S. in Aerospace Engineering from the University of Missouri-Rolla and an M.B.A. from Cornell University. About the Carillon Mitral Contour System The Carillon System offers a simple right heart approach to transcatheter mitral valve repair designed to reshape the anatomy and function of the mitral apparatus from the ...
Valcare Medical Ltd. developer of transcatheter mitral and tricuspid valve repair and replacement solutions, announces that it has successfully completed its first-in-human transseptal delivery of the AMEND™ annuloplasty ring. The transseptal AMEND procedure was performed at the Schulich Heart Centre at Sunnybrook Health Sciences Centre in Toronto, under ...
” An estimated 26 million people, worldwide, suffer from heart failure1 and of those, approximately 70 percent have functional mitral regurgitation. FMR is due to the mitral valve not closing tightly, resulting in blood flowing or leaking backwards through the mitral valve. ...
The Carillon System is a right heart transcatheter mitral valve repair (TMVr) device designed to treat the primary cause of FMR in patients with mitral regurgitation grades 2+, 3+ and 4+. ...
Dr. von Bardeleben heads the Heart Valve Center and Center of Cardiology at the University of Mainz. He is an internationally recognized authority in interventional cardiology leading a specialized center for advanced transcatheter treatment concepts. ...
Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the findings of a post hoc analysis of pooled prospectively collected data from three studies of the Carillon Mitral Contour System® with a focus on 5-year survival rate and ...
The Carillon System is a right heart transcatheter mitral valve repair (TMVr) device designed to treat the primary cause of FMR in patients with MR grades 2+, 3+ and 4+. ...